Yazar "Ozet, A." için listeleme
-
Antiangiogenic therapy in ovarian cancer for whom and when?
Bilgetekin, I.; Cetin, B.; Ozet, A. (Medical Communications, 2017)Tumor angiogenesis appears to be an important process in epithelial ovarian cancer development. Bevacizumab is a monoclonal antibody that can neutralize vascular endothelial growth factor, a promoter of the initiation phase ... -
Hepatotoxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: clinical practice and evidence
Cetin, B.; Bilgetekin, I.; Cengiz, M.; Ozet, A. (Springer International Publishing, 2017)Vascular endothelial growth factor (VEGF) plays an important role in the growth of tumor cells, and in their invasion, metastasis, and angiogenesis. Kinase inhibitors (which are taken orally, work intracellularly, and can ... -
The Potential for Chemotherapy-Free Strategies in Advanced Prostate Cancer
The treatment landscape for advanced prostate cancer is evolving rapidly, with new agents and strategies, and more optimal use of existing therapies under constant development. Efforts were focused on better understanding ...